STATINS LINKED TO LOWER RISK OF EARLY DEATH IN PATIENTS WITH COLORECTAL CANCER
==============================================================================


**MAY 9, 2019** - Use of statins before or after a diagnosis of colorectal cancer was linked with a lower risk of premature death, both from cancer and from other causes, in a Cancer Medicine analysis of published studies.

The meta-analysis included 14 studies involving 130,994 patients with colorectal cancer. Pre-diagnosis statin use was linked with a 15 percent lower risk of dying early from any cause and an 18 percent lower risk of dying from cancer. Post-diagnosis statin use was linked with a 14 percent lower risk of all-cause death and a 21 percent lower risk of cancer-specific death.

“Considering that statins are low-costed and wildly-used agents worldwide, we believe our updated meta-analysis can provide new insights into optimizing adjuvant treatment of colorectal cancer,” the authors wrote.

***Full citation:*** *Yue Li, Xingkang He, Yu’e Ding, Hongyang Chen, Leimin Sun. “Statins uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis” Cancer Medicine, 8 May 2019. <[https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.2151>](https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.2151>) DOI: 10.1002/cam4.2151.40892*

*Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd., reproduced with permission*.

*   Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.